Innovation Pharmaceuticals: Has The Stock Reached an Intermediate Bottom Yet?
IPIX

Clinical stage biopharmaceutical firm Innovation Pharmaceuticals (OTCQB:IPIX) has been gaining momentum in recent days. Last week, the company made a significant announcement and that has been the reason behind the momentum in the stock. Pre IND Meeting Request Submitted Last week, Innovation announced that it has submitted a pre-IND meeting request to the United States…